Banner
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 History
 Advertising
 
Have you been tested for sickle cell trait? Know your status!
 
Community Service Ad: American Red Cross, Together, we can save a life
 
Facilities
 


Industry News

Rare Disease Day

Search Articles: 
  • Pulmatrix receives IND approval for pulmazole phase 2 clinical study Pulmatrix announced the FDA completed its IND review and notified the Company that it is authorized to initiate a Phase 2 clinical investigation for Pulmazole (PUR1900) – an inhaled iSPERSETM formulation of the anti-fungal drug itraconazole for treatment of ABPA in patients with asthma.
    February 07, 2019

More...

 
Email thie page to a friend. Email This Page
to a Friend 		Print this page. Print This
Page
© 1997 - 2019 Info.Resource, Inc. All rights reserved.
Privacy Policy & Cookies . Terms of Use . About . Advertising

GeorgiaLifeScience.com is owned and published by Info.Resource, Inc.